1[1]Li C I,Daling J R,Malone K E.Age-specific incidence rates of in situ breast carcinomas by histologic type,1980 to 2001.Cancer Epidemiol Biomarkers Prev,2005,14:1008-1011.
2[2]Kepple J,Henry Tillman RS,Klimberg VS,et al.The receptor expression pattern in ductal carcinoma in situ predicts recurrence Am J Surg,2006,192:68-71.
3[3]Tsikitis V L,Chung M A.Biology of ductal carcinoma in situ classification based on biologic potential.Am J Clin Oncol,2006,29:305-310.
4[4]Boughey J C,Gonzalez R J,Bonner E,et al.Current treatment and clinical trial developments for ductal carcinoma in situ of the breast.Oncologist,2007,12:1276-1287.
5[5]Tavassoli F A,Devilee P.Intraductal Proliferative Lesions:Pathology and genetics of tumors of the breast and female genetic organs.Lyon:International Agency for Research on Cancer(IARC) Press,2003:63-73.
6[6]Patani N,Cutuli B,Mokbel K.Current management of DCIS:a review.Breast Cancer Res Treat,2008,111:1-10.
7[7]Ma X J,Salunga R,Tuggle J T,et al.Gene expression profiles of human breast cancer progression.Proc Natl Acad SciUSA,2003,100:5974-5979.
8[8]Perou C M,Sorlie T,Eisen M B,et al.Molecular portraits of human breast tumours.Nature,2000,406:747-752.
9[9]Meijnen P,Peterse J L,Antonini N,et al.Immunohistochemi calcategorization of ductal carcinoma in situ of the breast.Brit J Cancer,2008,98:137-142.
10[10]Boecker W,Buerger H,Schmitz K,etal.Ductal epithelial proliferations of the breast:a biological continuum?Comparativegenomic hybridization and high-molecular-weight cytokeratin expression patterns.J Pathol,2001,195:415-421.
10Lester SC, Connolly JL, Amin MB. College of American Pathologists protocol for the reporting of ductal carcinoma in situ [J]. Arch Pathol Lab Med, 2009, 133:13 -14.
